LADA is thought to be another form of Type 1 diabetes. It is difficult to diagnose because it progresses slowly, according to the report, which was published by NBC News on Jan. 7, and a correct diagnosis is confirmed through blood tests. Typically, LADA patients are older than 30 and do not require injectable insulin for at least six months after diagnosis but will depend on injectable insulin for the rest of their lives. The delay in symptoms leads many to be diagnosed as Type 2 diabetes.
LADA is often misdiagnosed due to the race, weight and age of patients, Kathleen Wyne, MD, PhD, an endocrinologist who leads the adult Type 1 diabetes program at Columbus-based Ohio State University, told KFF Health News.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
